Kneat.com Inc
TSX:KSI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Valuation Scenarios
If P/S returns to its 3-Year Average (8.8), the stock would be worth CA$5.75 (28% upside from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 6.8 | CA$4.48 |
0%
|
| 3-Year Average | 8.8 | CA$5.75 |
+28%
|
| 5-Year Average | 9.1 | CA$5.95 |
+33%
|
| Industry Average | 3.6 | CA$2.34 |
-48%
|
| Country Average | 1.9 | CA$1.23 |
-72%
|
Forward P/S
Today’s price vs future revenue
| Today's Market Cap | Revenue | Forward P/S | ||
|---|---|---|---|---|
|
CA$346.5m
|
/ |
Jan 2026
CA$63.3m
|
= |
|
|
CA$346.5m
|
/ |
Dec 2026
CA$79.5m
|
= |
|
|
CA$346.5m
|
/ |
Dec 2027
CA$98.5m
|
= |
|
|
CA$346.5m
|
/ |
Dec 2028
CA$124.2m
|
= |
|
|
CA$346.5m
|
/ |
Dec 2029
CA$186.5m
|
= |
|
|
CA$346.5m
|
/ |
Dec 2030
CA$223.8m
|
= |
|
|
CA$346.5m
|
/ |
Dec 2031
CA$257.4m
|
= |
|
|
CA$346.5m
|
/ |
Dec 2032
CA$283.1m
|
= |
|
Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | P/S | P/E | ||||
|---|---|---|---|---|---|---|
| IE |
|
Kneat.com Inc
TSX:KSI
|
432.6m CAD | 6.8 | -184.1 | |
| JP |
|
Medical Data Vision Co Ltd
TSE:3902
|
37.9T JPY | 9.7 | 227.5 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 5.4 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
25.5B USD | 8.9 | 31.2 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14B AUD | 57.3 | 60.7 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 3 | 20.5 | |
| SE |
|
Sectra AB
STO:SECT B
|
49.2B SEK | 21 | 91.5 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 7.2 | 19.2 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.1B USD | 3.6 | 35.7 | |
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
283.9B INR | 9.3 | 42.8 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
19.1B CNY | 8.8 | -62.1 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.8 |
| Median | 1.9 |
| 70th Percentile | 3.2 |
| Max | 3 099.8 |
Other Multiples
Kneat.com Inc
Glance View
kneat.com, Inc. engages in the design, development, and supply of software for data and document management. The company is headquartered in Limerick, Limerick and currently employs 165 full-time employees. The company went IPO on 2014-03-17. The firm's focus is to service the facilities, equipment and computer systems validation (CSV) market within the global life sciences industry. The firm designs develops and supplies software for data and document management within regulated environments. Its product, Kneat Gx, is a configurable, off-the-shelf application focused on validation lifecycle management and testing within the life sciences industry. Kneat Gx provides a compliant digital solution that enables companies in the life sciences industry to become compliant with an automated process. Its various validation processes include electronic logbook management, analytical instrument validation, utility and facility validation, process validation, method validation and equipment validation, among others.
